Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling

Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression

(2013) S. Feng et al.   CANCER RESEARCH

Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling

(2013) L.-Y. Fang et al.   CANCER RESEARCH

Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death

(2013) Simeng Wen et al.   CANCER TREATMENT REVIEWS

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation

(2013) Kouji Izumi et al.   EMBO Molecular Medicine

Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis

(2013) Tzu-Hua Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6->Androgen Receptor->TGF- ->MMP-9 Signals

(2013) X. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

(2013) C Chang et al.   ONCOGENE

Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling

(2013) J Luo et al.   ONCOGENE

Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer

(2013) C Sanchez et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling

(2013) T-H Lin et al.   Cell Death & Disease

Prostate Cancer Stem Cells

(2012) Shi-Ming Tu et al.   Clinical Genitourinary Cancer

Molecular Link Mechanisms between Inflammation and Cancer

(2012) D. B. Vendramini-Costa et al.   CURRENT PHARMACEUTICAL DESIGN

Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines

(2012) Kuo-Pao Lai et al.   EMBO Molecular Medicine

Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis

(2012) Wen-Lung Ma et al.   HEPATOLOGY

Fibroblast growth factors and their receptors in cancer

(2011) Jørgen Wesche et al.   BIOCHEMICAL JOURNAL

Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells

(2011) P. Ostling et al.   CANCER RESEARCH

Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy

(2011) Y. Sun et al.   CANCER RESEARCH

Effects of miR-541 on neurite outgrowth during neuronal differentiation

(2011) Jun Zhang et al.   CELL BIOCHEMISTRY AND FUNCTION

T Lymphocyte Recruitment into Renal Cell Carcinoma Tissue: A Role for Chemokine Receptors CXCR3, CXCR6, CCR5, and CCR6

(2011) Kimberley A. Oldham et al.   EUROPEAN UROLOGY

Infection, inflammation and prostate carcinogenesis

(2011) Maxwell Omabe et al.   INFECTION GENETICS AND EVOLUTION

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling

(2011) Wei Tan et al.   NATURE

Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence

(2011) J Teishima et al.   PROSTATE CANCER AND PROSTATIC DISEASES

FGF signalling in prostate development, tissue homoeostasis and tumorigenesis

(2010) Yongshun Lin et al.   BIOSCIENCE REPORTS

Intracellular adaptor molecules and AR signalling in the tumour microenvironment

(2010) Vikash Reebye et al.   CELLULAR SIGNALLING

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

(2010) Y Niu et al.   ONCOGENE

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters

(2009) Kathleen Ebelt et al.   EUROPEAN JOURNAL OF CANCER

Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients

(2009) Philippe O. Gannon et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Androgen Receptor and Invasion in Prostate Cancer

(2008) T. Hara et al.   CANCER RESEARCH

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

FGF-8 is involved in bone metastasis of prostate cancer

(2008) Maija P. Valta et al.   INTERNATIONAL JOURNAL OF CANCER

Prostate Cancer Stem Cells: A New Target for Therapy

(2008) Norman J. Maitland et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting the stromal androgen receptor in primary prostate tumors at earlier stages

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA